$Polyrizon (PLRZ.US)$ dump stock

$Polyrizon (PLRZ.US)$
$Transcode Therapeutics (RNAZ.US)$
the shorts are loving our low floats!

$Polyrizon (PLRZ.US)$ stock that goes down with good news means short attack if volume comes they will burn

$Polyrizon (PLRZ.US)$
Polyrizon's Breakthrough: New Intranasal Technology Could Transform Psychedelic Medicine Delivery

$Polyrizon (PLRZ.US)$ Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments
1 MINUTE AGO, 8:35 AM EDT
VIA GLOBENEWSWIRE

$Polyrizon (PLRZ.US)$
Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments
Friday, 14th March at 8:35 am
Raanana, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today that it has signed a non-binding Letter of Intent (LOI) with a biotech company focused...

$Polyrizon (PLRZ.US)$
Polyrizon's entry into the intranasal Naloxone space positions them in a growing market segment with established clinical need. Their approach focuses on potentially addressing key limitations of current intranasal Naloxone formulations through their proprietary T&T platform technology.
The intranasal route offers substantial advantages over injectable Naloxone - including ease of administration by non-medical personnel, elimination of needlesti...

$Polyrizon (PLRZ.US)$
Polyrizon's initiation of preclinical studies for intranasal Naloxone represents a strategic early-stage research milestone for this micro-cap biotech company. The company is targeting the opioid overdose treatment market with its Trap and Target™ (T&T) platform technology, which could potentially enhance drug delivery effectiveness.
The planned preclinical studies will evaluate fundamental parameters such as drug loading capacity, release kinetics,...

$Polyrizon (PLRZ.US)$
Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform

BUY IN NOW!!!!!!!!!!!!
$Polyrizon (PLRZ.US)$